Monoflange Versus Multiflange: Custom-Made Acetabular Implants in Revision Total Hip Arthroplasty
In brief
Monoflange hip implants achieved 93% bone integration versus 68% with multiflange
In this single-center review of 154 custom implants for revision hip surgery, complete bone integration was seen in 93% of monoflange implants and 68% of multiflange implants; infection was also less common with monoflange designs. Multiflange implants were linked to more removals, but design and treatment era were confounded, so prospective studies are needed to confirm the difference.
- Journal
- The Journal of arthroplasty (Q1)
- Published
- 16 November 2026
- Study design
- Prospective / inception cohort
- Evidence level
- Level 2, Moderate (CEBM 2b)
- Authors
- Mari Babasiz, Alberto Alfieri Zellner, Tamara Babasiz, Elio Assaf, Frank Sebastian Fröschen, Andreas Christian Strauss, et al.
- PMID
- 43039056
- DOI
- 10.1016/j.arth.2026.11.058
Why clinicians should know about it
- Picked for Orthopedics and Sports Medicine (paper of the day, 21 November 2026): Compares custom implants in revision hip arthroplasty
Abstract
BACKGROUND: Severe acetabular bone loss remains a major challenge in hip reconstruction. Custom-made acetabular components (CMACs) represent a valuable treatment option, with monoflange designs potentially offering advantages over multiflange constructs by reducing implant size and soft-tissue exposure while maintaining mechanical stability. METHODS: This retrospective, single-center study analyzed 154 CMACs (101 monoflange and 53 multiflange) and assessed clinical outcomes (Oxford Hip Score), radiographic findings, complications, implant survival, and revision procedures. The mean follow-up was 37.0 months (range, 6.2 to 168.2), with longer follow-up for multiflange than monoflange constructs (55.5 versus 27.3 months; P = 0.011). RESULTS: Monoflange constructs showed shorter hospital stays (P = 0.030), reduced blood losses (P < 0.001), and shorter operative times (P = 0.006). Both groups improved in Oxford Hip Score (OHS), with higher postoperative scores for monoflange constructs (P = 0.010), although adjusted mean change in OHS did not differ (P = 0.566). Periprosthetic joint infection rates were higher for multiflange constructs (18.9 versus 6.9%; P = 0.034). Complete osseointegration was achieved in 93.1% of monoflange and 67.9% of multiflange constructs (P < 0.001). Horizontal center of rotation restoration was comparable (0.9 ± 5.0 versus 2.0 ± 5.7 mm; P = 0.236), whereas monoflange constructs showed less cranialization (3.5 ± 4.5 mm versus 7.6 ± 5.6 mm; P < 0.001). Multiflange design was associated with a higher risk of implant removal (odds ratio = 4.42; P = 0.007). CONCLUSION: Monoflange CMACs demonstrated favorable clinical and radiographic outcomes and, after adjustment for patient factors, a significantly lower risk of implant removal than multiflange constructs. As implant design and era are confounded in this cohort, these findings should be interpreted as associations and require confirmation in prospective series.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.